Amelogenesis imperfecta (AI) is a clinically and genetically heterogeneous group of diseases characterized by enamel defects. The authors have identified a large consanguineous Moroccan family segregating different clinical subtypes of hypoplastic and hypomineralized AI in different individuals within the family. Using targeted next-generation sequencing, the authors identified a novel heterozygous nonsense mutation in COL17A1 (c.1873C>T, p.R625*) segregating with hypoplastic AI and a novel homozygous 8-bp deletion in C4orf 26 (c.39_46del, p.Cys14Glyfs*18) segregating with hypomineralized-hypoplastic AI in this family. This study highlights the phenotypic and genotypic heterogeneity of AI that can exist even within a single consanguineous family. Furthermore, the identification of novel mutations in COL17A1 and C4orf 26 and their correlation with distinct AI phenotypes can contribute to a better understanding of the pathophysiology of AI and the contribution of these genes to amelogenesis.
Introduction
Enamel is the hardest and most mineralized tissue in the human body. It is composed primarily of calcium hydroxyapatite crystallites (96%) with a small amount of water (2%) and an organic matrix (2%). The organic matrix contains several proteins, such as amelogenin, ameloblastin, enamelysin, enamelin, tuftelin, and amelotin (Cobourne and Sharpe 2013) . Enamel formation, or amelogenesis, is an intricate process that begins with the deposition of a thin layer of aprismatic enamel by secretory ameloblasts during the bell stage of tooth development. These cells then develop Tomes processes, which secrete enamel proteins along a mineralization front and control rod formation as the enamel crystals grow in length. Then, the ameloblasts lose their Tomes processes, lay a final layer of aprismatic enamel, and enter the maturation phase, during which they secrete proteases to degrade the enamel matrix, allowing the deposition of ions that is necessary for the hydroxyapatite crystallites to grow in size (Hu et al. 2007) .
Defects in amelogenesis can lead to a group of hereditary diseases characterized by enamel defects called amelogenesis imperfecta (AI). The prevalence of AI varies between 1 in 700 to 1 in 14,000 depending on the population studied (Crawford et al. 2007 ). To date, mutations in 15 genes (AMELX, ENAM, AMBN, KLK4, MMP20, WDR72, FAM83H, ITGB6, SLC24A4, C4orf26, LAMB3, LAMA3, COL17A1, DLX3, and STIM1) have been shown to cause nonsyndromic AI (Lagerstrom et al. 1991; Rajpar et al. 2001; Hart et al. 2004; Dong et al. 2005; Kim et al. 2005; Murrell et al. 2007; Kim et al. 2008; El-Sayed et al. 2009; Parry et al. 2012; Yuen et al. 2012; Parry et al. 2013; Poulter et al. 2014a; Poulter et al. 2014b; Poulter et al. 2014c ; Wang et al. 2014 ). Mutations in several additional genes have been demonstrated to cause various syndromic forms of AI, such as in DLX3 (tricho-dento-osseous syndrome), FAM20A (enamel-renal syndrome), CNNM4 (Jalili syndrome), ROGDI (Kohlschutter-Tonz syndrome), LTBP3 (brachyolmia with AI), PEX1 and PEX6 (Heimler syndrome), and CLDN16 (familial hypomagnesemia with hypercalciuria and nephrocalcinosis) to name a few (Price et al. 1998; Parry et al. 2009 ; 663200J DRXXX10.1177/0022034516663200Journal of Dental ResearchAmelogenesis Imperfecta research-article2016 Jaureguiberry et al. 2012; Schossig et al. 2012; Bardet et al. 2015; Huckert et al. 2015; Ratbi et al. 2015) .
The inheritance of isolated AI can be autosomal dominant (AD), autosomal recessive (AR), or X-linked depending on the underlying gene defect. Phenotypically, the disease is broadly classified into 1) hypoplastic AI, which is a quantitative defect characterized by very thin or no enamel, pitted enamel, or enamel with grooves and is caused by defects in enamel matrix secretion; and 2) hypomineralized AI, which is a qualitative defect characterized by soft enamel due to defects in enamel mineralization/maturation. This latter subtype can be further classified into hypocalcified AI, defined as reduced mineralization of enamel, and hypomature AI, caused by protein processing and enamel crystallite maturation defects. However, such a classification does not reflect the fact that both quantitative and qualitative defects can present in any one type of AI, thus rendering AI difficult to describe and classify at times.
In this study, we present genetic analyses in a large consanguineous Moroccan family segregating 2 AI phenotypes (hypoplastic only and hypoplastic + hypomineralized) in different individuals. Using a targeted next-generation sequencing (NGS) approach, we identified novel mutations in COL17A1 and C4orf26 segregating with the disease in different members of this family, with a clear genotype-phenotype correlation between the 2 forms of AI and the mutations identified.
Materials and Methods

Patient Inclusion
The family was recruited at the Faculty of Dental Medicine, Mohammed V University in Rabat, Morocco, and included in this study, which has been approved by the French Ministry of Higher Education and Research (MESR). It is registered at https://clinicaltrials.gov (NCT01746121 and NCT02397824) and with the MESR's Bioethics Commission as a biological collection ("Orodental manifestations of rare diseases" DC-2012-1677 within DC-2012-1002). It was acknowledged by the CPP (Person Protection Committee; Est IV) on December 11, 2012. All patients or their legal guardians provided informed consent for clinical data collection, DNA extraction, and analysis. DNA was obtained from saliva samples (Oragene DNA; DNA Genotek). The patient phenotype was recorded using D[4]/Phenodent (www.phenodent.org). Dental phenotyping was performed via clinical and X-ray examinations (panoramic radiography).
Library Preparation, Sequencing, and Data Analysis
Targeted regions were captured using a custom SureSelectXT2 in-solution target enrichment kit (Agilent) as described previously (Prasad et al. 2016) . Sequencing libraries were prepared for sequencing (2 × 100 bp) on the HiSeq 2500 (Illumina) following the manufacturers' instructions. Read alignment and variant calling and annotation were performed using standard methods as previously described and detailed in the Appendix (Prasad et al. 2016 ).
Mutation Validation
The mutations were validated, and segregation analysis was performed by polymerase chain reaction (PCR) followed by Sanger sequencing (GATC). Primer sequences for the amplification of the COL17A1 mutation are the following: 5′-TTC CAGGGATGTCAGATGGG-3′ and 5′-TCAAAGGGTCAC TCTGGCTT-3′; those for the amplification of the C4orf 26 mutation are the following: 5′-TGATCCCCAACTCTCCA CTG-3′ and 5′-ATTGCTGAGACGAGGACCAA-3′. PCR reactions were set up with 50 ng genomic DNA, 0.5 μm each primer, 1.5 mM MgCl 2 , 1 mM each dNTP, 1 U Taq polymerase (D1806; Sigma-Aldrich), and 1X PCR buffer (D1806; Sigma-Aldrich). Cycling conditions were as follows: 95°C for 5 min, 40 cycles of 95°C for 30 s, 63.9°C for 30 s, 72°C for 30 s, and 72°C for 10 min. The product sizes were 715 bp for the C4orf26 amplicon and 501 bp for the COL17A1 amplicon.
Results
Clinical Assessment of the Family Reveals Hypomineralized and Hypoplastic AI
We recruited a large highly consanguineous Moroccan family segregating AI in 2 branches of the family. The mutation identified in the index patient, IV-3, was recently reported by us as part of a large-scale diagnostic screen of patients with rare diseases with orodental manifestations using a targeted NGS panel (Prasad et al. 2016 ). Here, we present an extended pedigree ( Fig. 1A) with new clinical data on this patient as well as on additional members of his family. Furthermore, we also present genotypic analyses in additional family members and a novel mutation in a second gene segregating with AI in this family. Overall, we have clinically examined 9 members of the family and genotyped 8 members.
The index patient, IV-3, presented with thin hypoplastic enamel in the primary dentition and pitted enamel in erupting permanent teeth, which showed a rough surface ( Fig. 1B) . Dental radiograph findings were normal (Fig. 1C ). His sister, IV-4, who was still in the primary dentition stage, presented with yellowish enamel and enamel hypoplasia in the incisors and molars (Fig. 1E ). Enamel seemed to be present only at the tip of the cusps. Dental radiographs showed no contrast between dentin and enamel, both in erupted and nonerupted teeth, suggesting enamel hypomineralization ( Fig. 1F ). Their father, III-12, presented with discrete, thinner, pitted striae enamel ( Fig. 1D ) and a normal dental X-ray result (data not shown). The appearance of their mother's (III-9) teeth was clinically normal (Fig. 1G ).
In the second branch of the family, the cousins of IV-3, that is, IV-5 and IV-6, also presented with AI. IV-5 was in his permanent dentition. In Figure 1H , we can notice that his mandibular teeth (before prosthodontic treatment) were dark brown and that the incisors were covered with calculus. Enamel hypomineralization led to posteruptive breakdown, severe tooth wear, and loss of vertical bite dimension. IV-6, who was in his primary dentition stage, showed brown teeth with hypomineralized-hypoplastic enamel with signs of posteruptive enamel loss (Fig. 1K, L) . On the panoramic radiograph, IV-4, IV-5, and IV-6 displayed a similar absence of contrast between the mineralized tissues of the teeth, confirming the diagnosis of hypomineralized AI (Fig. 1F , I, L). Their father, III-11, the brother of III-12, showed thin enamel with diastema between the teeth (Fig. 1J ). His teeth were slightly yellow in color. The , and striae anomalies is present in affected III-12, III-11, III-13, and IV-3 individuals with a heterozygous COL17A1 mutation. (G) The normal dentition of a heterozygous carrier of the C4orf 26 mutation. (H) The maxillary teeth have undergone prosthodontic treatment, whereas the mandibular teeth demonstrate the hypomineralized AI phenotype for IV-5. This phenotype with yellow-brown hypomineralized enamel combined with hypoplastic defects is shared by IV-4 (E) and IV-6 (K) and is associated with a homozygous C4orf 26 mutation. mother of IV-5 and IV-6, III-10, who is also the sister of III-9, had clinically normal teeth (data not shown). The sister of III-11 and III-12, that is, III-13, also had a phenotype similar to her brothers: hypoplastic AI with pitted enamel (Fig. 1M) .
The remaining family members were reported to have normal teeth. In spite of the consanguinity of the family, the disease shows an AD transmission in each affected branch of the family (branch 1: III-9, III-12, IV-3, and IV-4; branch 2: III-10, III-11, IV-5, and IV-6), with the fathers and all children being affected ( Fig. 1A) . However, the clinical phenotypes vary among affected individuals. IV-4, IV-5, and IV-6 all showed a similar phenotype with yellow or brown hypomineralized enamel with hypoplasia. III-11, III-12, and IV-3 showed a primarily hypoplastic enamel defect.
Targeted NGS Reveals Mutations in 2 Genes
We performed targeted NGS in patient IV-3 as previously described (Prasad et al. 2016) . Briefly, we sequenced 585 genes (2.7 Mb) that were either implicated in syndromic and nonsyndromic orodental diseases or were considered candidate genes for these diseases. We generated 1.2 Gb of sequence data. Of these, 4.3 million nucleotides passed filters and aligned within the targeted regions, providing a mean coverage of 169.13×, with 97.4% of targeted nucleotides covered at ≥20×. We identified 2,568 variants, including 2,129 single nucleotide polymorphisms (SNPs) and 439 insertion/deletion variants (INDELs). In order to identify potential pathogenic variants, we filtered out variants that were present at an allele frequency ≥1% in the database of SNPs (dbSNP) and in the 1000 Genomes Project Consortium (1000 Genomes Project Consortium et al. 2015 and Exome Variant Server (EVS) (NHLBI GO Exome Sequencing Project 2015) databases, as well as our in-house database of control exomes. We further prioritized variants that caused a nonsynonymous splice site or frameshift change in a protein-coding transcript. Owing to the consanguinity of the family, but the apparent dominant transmission of AI within each branch of the family, we considered all homozygous and heterozygous variants. This led to the identification of 2 heterozygous mutations: a nonsense mutation in COL17A1 (NM_000494.3:c.1873C>T, p.Arg625*) and an 8-bp deletion in C4orf26 (NM_001206981.1:c.39_46del, p.Cys14Glyfs*18). Both mutations are absent in the 1000 Genomes Project Consortium and EVS databases and in our in-house database. The C4orf 26 mutation is also absent in the Exome Aggregation Consortium (ExAC) database, whereas the COL17A1 mutation is present in 1 out of 121,206 chromosomes assayed (Lek et al. 2015) . Both mutations were validated by Sanger sequencing (Fig. 2) . Raw NGS data files and Sanger sequencing files will be made available upon request.
Previously, mutations in COL17A1 have been shown to cause AD hypoplastic AI, whereas mutations in C4orf 26 have been shown to cause AR hypomineralized AI (Murrell et al. 2007; Parry et al. 2012) . Manual inspection of sequencing reads aligning to C4orf 26 did not reveal any additional mutations in this gene in IV-3. Furthermore, we did not identify any heterozygous or homozygous deletions in this gene from NGS data, suggesting that the COL17A1 mutation was responsible for AI in this patient.
Owing to the presence of protein-disrupting mutations in 2 known AI genes, we tested the segregation of both mutations in other family members. Segregation analysis demonstrated that the COL17A1 mutation was inherited from the affected father, III-12, who was also heterozygous for the C4orf 26 mutation. The unaffected mother was also heterozygous for the C4orf26 mutation but lacked the COL17A1 mutation. Surprisingly, the affected sister, IV-4, was homozygous for the C4orf 26 variant and did not carry the COL17A1 mutation. In the second branch of the family (i.e., III-10, III-11, IV-5, and IV-6), both affected children (IV-5 and IV-6) were homozygous for the C4orf26 Figure 2 . Segregation analysis of the COL17A1 and C4orf26 mutations. Sequence chromatograms demonstrate the presence/absence of the 2 mutations in the indicated family members. The heterozygous COL17A1 c.1873C>T mutation is highlighted by a red asterisk, whereas the presence of the homozygous C4orf 26 c.39_46del mutation is indicated in red. mutation and lacked the COL17A1 mutation. Their parents were both heterozygous for the C4orf 26 deletion. Their unaffected mother lacked the COL17A1 mutation, whereas their affected father (III-11) was heterozygous for the COL17A1 mutation. DNA was not available for any other family members. However, given the phenotype of III-13, it is likely that she is also a heterozygous carrier of the COL17A1 mutation. The presence of this mutation in 3 siblings suggests that it was inherited from one of the parents, that is, II-5 or II-6. However, no clinical information was available on these 2 individuals, and no DNA was available either. Interestingly, the COL17A1 mutation segregated with individuals with pitted hypoplastic AI, whereas the C4orf 26 mutation segregated with individuals with hypomineralized-hypoplastic AI.
The COL17A1 mutation introduces a premature termination codon (PTC) in the extracellular col15 domain, the largest collagenous domain in the protein. The PTC-containing transcript is expected to be degraded by nonsense-mediated decay (NMD), causing haploinsufficiency of the protein. If the transcript escapes NMD, the resulting protein would be expected to lack the C-terminal 873 aa of the protein. This protein may either be nonfunctional, causing haploinsufficiency of the gene, or may interfere with the formation of collagen trihelices, thus exerting a dominant negative effect on the wild-type protein. Although the precise mechanism is unclear, the mutation is expected to abrogate normal protein expression/function. The position of this mutation in the protein sequence of COL17A1 is shown in Figure 3A with respect to those of previously reported mutations in the gene that were associated with an isolated enamel phenotype in the heterozygous state (McGrath et al. 1996; Floeth and Bruckner-Tuderman 1999; Vaisanen et al. 2005; Murrell et al. 2007; Prasad et al. 2016) .
The C4orf 26 mutation is expected to cause a loss of function of the gene, similarly to previously reported mutations in this gene (Fig. 3B) . The deletion causes a frameshift that introduces a PTC at 32 aa of the 130 aa protein.
If the RNA transcript is not degraded by NMD, the resulting protein is expected to be nonfunctional as it would lack important protein motifs (Fig. 3B) .
Therefore, we posit that both mutations cause AI in this family in a mutually exclusive manner. The COL17A1 mutation is responsible for hypoplastic AI in the heterozygous state, whereas the C4orf26 mutation is responsible for hypomineralized-hypoplastic AI in the homozygous state. The presence of the COL17A1 mutation in 1 individual in the heterozygous state in the ExAC database may either be a false-positive call from NGS data or may be an individual who was recruited in spite of their AI phenotype, which can sometimes be discrete.
Discussion
We have identified 2 novel mutations in COL17A1 and C4orf 26 responsible for AI in a single consanguineous family. Our study presents an unusual and rather unique family, highlighting the genetic and clinical heterogeneity of AI and the advantage of using an NGS approach for the molecular diagnosis of this group of diseases. Our article also exemplifies the phenotype-genotype correlation between certain forms of AI and the underlying genetic mutation.
Biallelic mutations in COL17A1 are known to be responsible for junctional epidermolysis bullosa (JEB), non-Herlitz type, a very rare AR disorder characterized by skin and mucosal blistering, nail dystrophy, and enamel defects (McGrath et al. 1995) . Some heterozygous carriers have been reported to manifest enamel defects (McGrath et al. 1996; Floeth and Bruckner-Tuderman 1999; Murrell et al. 2007) . This is consistent with the finding that mutations in LAMB3 and LAMA3, genes originally identified as responsible for AR JEB, were also identified in autosomal-dominant amelogenesis imperfecta (AD AI) (Yuen et al. 2012; Poulter et al. 2014b) . We recently showed that COL17A1 is likely a major gene responsible for AD AI, with 8% of our AI cohort carrying a heterozygous deleterious mutation in this gene (Prasad et al. 2016) . COL17A1, LAMB3, and LAMA3 all encode proteins that form components of the hemidesmosome, an important junctional adhesion structure that binds epithelial cells to the underlying mesenchyme (Borradori and Sonnenberg 1999) . Studies in a mouse Col17a1 knockout model demonstrated that Col17a1 is expressed in presecretory, secretory, and maturation-stage ameloblasts (Asaka et al. 2009 ). Furthermore, ameloblasts from Col17a1 -/showed reduced differentiation, lack of Tomes processes, and reduced enamel matrix secretion, leading to malformed enamel rods and an irregular enamel matrix (Asaka et al. 2009 ). This is consistent with the hypoplastic thin or pitted enamel phenotype Pasmooij et al. 2007 ) and annotated with mutations that have been described to cause enamel defects in the heterozygous state. The mutation described in this study is shown in red. The remaining mutations were described in Murrell et al. (2007) Parry et al. 2012 ) and annotated with known pathogenic mutations. The mutation described in this study is shown in red. The remaining mutations were described in Parry et al. (2012) . seen in our patients and previously described and illustrated by Murrell et al. (2007) and Prasad et al. (2016) .
The molecular mechanism by which heterozygous mutations in COL17A1 cause AI is unclear. Discovery of the G627V mutation, which destabilizes triple-helix folding in vitro, suggested a dominant negative effect (Tasanen et al. 2000) . However, subsequent discovery of the c.823delA mutation that leads to a complete lack of gene products complicated this picture. Of the remaining COL17A1 mutations identified to date to cause AD AI (Fig. 3) , all are either nonsense or splice-site mutations. The nonsense mutations are expected to cause NMD of the mutated transcript, leading to haploinsufficiency of the gene product. However, if these transcripts escape NMD, they could be translated into incomplete protein fragments that may exert a dominant negative effect on homotrimer formation. For example, the c.2336-2A>G mutation is expected to cause in-frame exon deletion and the loss of 9 amino acids in the protein that is expected to disrupt the structure of the homotrimer (Chavanas et al. 1997) , consistent with a dominant negative effect. Yet, a patient carrying a homozygous c.2336-2A>G mutation was found to have a complete lack of COL17A1 mRNA (Chavanas et al. 1997) , casting doubt once again on the pathogenic mechanism of this mutation. Similarly, the c.1141+ 1G>A mutation is expected to cause either in-frame skipping of exon 14 or retention of exon 14 with the introduction of a PTC (Prasad et al. 2016 ). Further molecular and biochemical studies in patient samples will be necessary to determine the precise molecular mechanism of the pathogenicity of heterozygous COL17A1 mutations in AI.
Our study is only the second report of mutations in C4orf 26 in AI. Consistent with the observations of Parry et al. (2012) , individuals in our study who were homozygous for the 8-bp deletion in C4orf 26 had a hypomineralized form of AI, with yellowish-brown and hypomineralized enamel with partial, mild developmental hypoplasia, whereas heterozygous carriers had normal dentition. Interestingly, although IV-5 and IV-6 carry the same homozygous mutation, the phenotype seems more severe in IV-5, whose enamel is very colored due to the absorption of extrinsic pigments and some posteruptive enamel breakdown (clearly visible in the lower incisors in Fig. 1H ). This image was taken when the patient was in his permanent dentition stage. The photograph of IV-6, on the other hand, was taken when he was in his primary dentition stage (Fig. 1K) . The lighter enamel coloration as compared to IV-5 may be due to reduced enamel thickness in the primary dentition. The panoramic radiograph (Fig. 1L) , which was taken during the mixed dentition phase, demonstrates the absence of contrast between enamel and dentin, the hallmark of hypomineralized AI. Although the exact role of C4orf 26 in amelogenesis is unknown, it is thought to play a role in hydroxyapatite crystallite growth . This is consistent with the presence of hypomineralized enamel in patients with a mutation in this gene.
Disease transmission in a consanguineous family is usually assumed to be the result of mutations that are homozygous by descent. Therefore, the consanguineous family that we present here is very unusual and interesting because of the segregation of mutations in 2 different genes. Although such a situation is rather rare, there has been some precedent in the literature for consanguineous families segregating mutations at different loci responsible for the same or similar disease. For example, a large consanguineous Lebanese family with multiple individuals from distinct sibships all affected with Bardet-Biedl syndrome, a rare pleiotropic ciliopathy, was found to be segregating 3 mutations in 2 different genes: BBS2 and BBS10 (Laurier et al. 2006) . Similarly, a consanguineous nuclear family with multiple siblings affected with either nonsyndromic retinitis pigmentosa (RP) or RP associated with hearing loss was found to be segregating mutations in 2 genes: in MYO7A in individuals with syndromic RP and in PDE6B in individuals with nonsyndromic RP (Goldenberg-Cohen et al. 2013) . The elucidation of the genetic cause of AI in the family presented herein was no doubt facilitated by the use of targeted NGS, as we were able to simultaneously screen all known genes responsible for this genetically and phenotypically extremely heterogeneous disease. To the best of our knowledge, this is the only reported consanguineous AI family segregating mutations at distinct loci. The now prevalent use of NGS-based analyses will likely reveal further such unusual cases.
In conclusion, we have used targeted NGS to dissect the genetics of AI in a large consanguineous family segregating different AI subtypes. In doing so, we have identified novel mutations in COL17A1 and C4orf 26 that are responsible for distinct forms of AI.
